FACTORS ASSOCIATED WITH THE OUTCOMES OF ANCA-ASSOCIATED GLOMERULONEPHRITIS: A MULTICENTER RETROSPECTIVE COHORT STUDY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/e8b5cd1e7daafaffa87b65599789f693.pdf
FACTORS ASSOCIATED WITH THE OUTCOMES OF ANCA-ASSOCIATED GLOMERULONEPHRITIS: A MULTICENTER RETROSPECTIVE COHORT STUDY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Nikolay
Bulanov
Nikolay Bulanov nmbulanov@gmail.com Sechenov First Moscow State Medical University Department of Internal, Occupational Diseases and Rheumatology Moscow Russia *
Anastasiia Zykova ansezy@gmail.com Botkin Hospital Department of Nephrology Moscow Russia -
Ekaterina Stoliarevich stolyarevich@yandex.ru Moscow City Clinical Hospital 52 Department of Pathology Moscow Russia -
Dmitrii Starikov dmitrij.starikov.6991@gmail.com Moscow City Clinical Hospital 52 Department of Pathology Moscow Russia -
Mayra Bulanova doctorbulanova@gmail.com Vladimir Regional Clinical Hospital Department of Nephrology Vladimir Russia -
Ekaterina Tao karovaikinaea@gmail.com Sechenov First Moscow State Medical University Publishing Center Moscow Russia -
Mariia Litvinova maria.litvinova.2015@yandex.ru Sechenov First Moscow State Medical University Department of Internal, Occupational Diseases and Rheumatology Moscow Russia -
Alexey Skvortsov alex.v.skvortsov13@yandex.ru Sechenov First Moscow State Medical University Department of Internal, Occupational Diseases and Rheumatology Moscow Russia -
Sergey Moiseev avt420034@gmail.com Sechenov First Moscow State Medical University Department of Internal, Occupational Diseases and Rheumatology Moscow Russia -
Helena Zakharova helena.zakharova@gmail.com Botkin Hospital Department of Nephrology Moscow Russia -
 
 
 
 
 

Kidney involvement is one of the most severe manifestations of ANCA-associated vasculitis (AAV) characterized by unfavorable outcomes. The aim of the study was to identify factors associated with kidney survival in patients with biopsy proven ANCA-associated glomerulonephritis (ANCA-GN).

In our multicenter retrospective cohort study, we enrolled adult (≥18 years) patients with biopsy-proven ANCA-GN who were followed between 2014 and 2025. All patients were stratified according to the histopathologic class (Berden et al), ANCA Renal Risk Score (ARRS), and ANCA Kidney Risk Score (AKRiS). 

The primary end-point was time to CKD G5 as defined by KDIGO (2024). Time-to-event was measured from the date of kidney biopsy. Kidney function was measured in serum creatinine and GFR was estimated with the 2021 CKD-EPI (creatinine) equation.

Cox proportional hazards, Kaplan–Meier curves, Harrell’s C-statistic, and receiver operating characteristics were used to compare the characteristics of the prognostication tools.

The study was approved by the Sechenov University local ethics committee (#10-22, 19.05.2022).

We enrolled 195 patients, 85 (44%) males and 110 (56%) females. Median age at AAV onset was 54 (37; 60) years. The majority of patients (88%) were ANCA-positive. Thirty-nine (20%) patients were diagnosed with renal-limited AAV. Median Birmingham vasculitis activity score (BVAS v.3) at biopsy was 14 (12; 18). Median follow-up was 40 (15; 75) months.

Fifty-five (28%) patients developed CKD G5 (fig. 1). Histopathologic classification demonstrated a significantly lower predictive ability (Harrel’s C=0.669, 95% CI 0.599-0.739) compared to ARRS (C=0.790, 95% CI 0.741-0.839, p<0.001) and AKRiS (C=0.798, 95% CI 0.745-0.851, p=0.003).

In the first multivariate Cox regression model, sclerotic class (HR 3.86 [1.01–14.72]), baseline eGFR <15 mL/min/1.73 m2 (HR 11.30 (3.14-40.65]), IFTA >25% (HR 2.71 [1.21–6.09]), dialysis dependance at the time of biopsy (HR 2.77 (1.26–6.08]), and acute tubular necrosis (ATN, HR 2.65 [1.12–6.32]) showed significant association with CKD G5. In the second multivariate Cox regression model, ARRS high risk group (HR 4.47 [1.16–17.20]), hemoglobin <100 g/L (HR 2.73 [1.27–5.90]), global glomerulosclerosis ≥50% (HR 3.39 (1.53–7.49]), dialysis dependance at the time of biopsy (HR 3.57 [1.71–7.45]), and ATN (HR 2.33 [1.02–5.31]) were significantly associated with the outcome. In the multivariate Cox regression model 3, AKRiS very high risk group (HR 10.24 [3.08–34.07]), hemoglobin <100 g/L (HR 2.47 [1.02–5.95]), global glomerulosclerosis ≥50% (HR 4.79 [2.25 – 10.21]), dialysis dependance at the time of biopsy (HR 3.94 [1.80 – 8.62]), and ATN (HR 2.65 [1.13–6.21]) were associated with the outcome. Female sex was associated with a significantly lower risk of kidney outcome in all three models.

Figure 1. Kaplan-Meier curves showing kidney survival according to the histopathologic classification (A) and different risk groups according to ARRS (B) and AKRiS (C).

In our multicenter cohort, sclerotic class, high risk and very high risk groups stratified according to ARRS and AKRiS, respectively, global glomerulosclerosis ≥50%, ATN, baseline hemoglobin <100 g/L, and dialysis dependance at the time of kidney biopsy were significantly associated with worse renal survival in patients with ANCA-GN.

Kewords